CliffBio
small molecule

MONOFERRIC

FERRIC DERISOMALTOSE

Loss of exclusivityJune 2036latest FDA-listed patent expiry
CompanyPHARMACOSMOS AS

Drug detail

Brand nameMONOFERRIC
Active ingredientFERRIC DERISOMALTOSE
Strength100MG/ML (100MG/ML)
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalJanuary 2020
Marketing statusDISCN

Listed patents

PatentExpiresType
11633489June 2036use U-3594
8815301August 2029substance, product
10414831March 2029substance, product
12030962March 2029substance, product
11851504March 2029substance, product

More from PHARMACOSMOS AS

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

MONOFERRIC patent cliff — loss of exclusivity June 2036 | CliffBio